載入...
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
Allogeneic hematopoietic stem cell transplantation (HSCT) represents the only curative treatment for patients with myelodysplastic syndrome (MDS), but involves non-negligible morbidity and mortality. Registry studies have shown that advanced disease stage at transplantation is associated with inferi...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Blackwell Publishing Ltd
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736162/ https://ncbi.nlm.nih.gov/pubmed/23606215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23458 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|